These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6896645)

  • 1. Absolute and relative bioavailability of lithium dosage forms in the beagle dog.
    Banarer M; Ritschel WA
    Arzneimittelforschung; 1982; 32(4):383-8. PubMed ID: 6896645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of noreximide in the beagle dog.
    Koch HP; Bykadi G; Ledesma B; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1982; 4(8):587-90. PubMed ID: 7169847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of PFA (trisodium phosphonoformate) after i.v. and p.o. administration to beagle dogs and rabbits.
    Ritschel WA; Grummich KW; Hussain SA
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):41-8. PubMed ID: 3157841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meperidine pharmacokinetics following intravenous, peroral and buccal administration in beagle dogs.
    Ritschel WA; Neub M; Denson DD
    Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):811-5. PubMed ID: 3441166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and bioavailability of beta-sitosterol in the beagle dog.
    Ritschel WA; Kastner U; Hussain AS; Koch HP
    Arzneimittelforschung; 1990 Apr; 40(4):463-8. PubMed ID: 2357248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tiapride and absolute bioavailability of three extravascular forms.
    Rey E; d'Athis P; Richard MO; de Lauture D; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):62-7. PubMed ID: 7061180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phencyclidine (PCP) disposition kinetics in dogs as a function of dose and route of administration.
    Woodworth JR; Owens SM; Mayersohn M
    J Pharmacol Exp Ther; 1985 Sep; 234(3):654-61. PubMed ID: 4032285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal bioavailability of lidocaine in the dog: evaluation of first-pass elimination.
    Ritschel WA; Grummich KW; Hussain AS; Denson DD; Ritschel BE
    Methods Find Exp Clin Pharmacol; 1987 Aug; 9(8):497-502. PubMed ID: 3695734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium dosage regimen design by the repeated one-point method.
    Ritschel WA; Banarer M
    Arzneimittelforschung; 1982; 32(2):98-102. PubMed ID: 7199926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioavailability of lithium from tablets containing different lithium salts].
    Leucuţa S; Fodoreanu L; Pop R; Barna D; Kovãcs A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(2):145-8. PubMed ID: 6216569
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics and bioavailability of diltiazem (CRD-401) in dog.
    Kohno K; Takeuchi Y; Etoh A; Noda K
    Arzneimittelforschung; 1977 Jul; 27(7):1424-8. PubMed ID: 578467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
    Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation of a theophylline oral controlled-release unit dosage form.
    Gangadharan B; Ritschel WA; Hussain SA
    Arzneimittelforschung; 1987 Nov; 37(11):1256-7. PubMed ID: 3440033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of coumarin and 7-hydroxycoumarin upon i.v. and p.o. administration in the euthyroid and hypothyroid beagle dog.
    Ritschel WA; Grummich KW
    Arzneimittelforschung; 1981; 31(4):643-9. PubMed ID: 7195711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
    Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, bioavailability, and dosage regimens of digoxin in dogs.
    Button C; Gross DR; Johnston JT; Yakatan GJ
    Am J Vet Res; 1980 Aug; 41(8):1230-7. PubMed ID: 7447117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability studies of calcium dobesilate--a case of flip-flop kinetics.
    Franke G; Schneider T; Siegmund W; Scherber A
    Pharmazie; 1985 Aug; 40(8):562-3. PubMed ID: 4080804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.